Andrew J. Schwab insider trades

Open-market stock purchases and sales by Andrew J. Schwab, Unknown at Skye Bioscience, Inc, from SEC Form 4 filings since Feb 18, 2014.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -65%.

Recent trades

DateStockTradeValue
Sep 23, 2026SKYE Skye Bioscience, IncSold$185K
Sep 23, 2026SKYE Skye Bioscience, IncSold$7.3K
Sep 22, 2026SKYE Skye Bioscience, IncSold$45.6K
Sep 22, 2026SKYE Skye Bioscience, IncSold$1.8K
Sep 16, 2026SKYE Skye Bioscience, IncSold$2.5K
Sep 16, 2026SKYE Skye Bioscience, IncSold$62.3K
Aug 27, 2026CAMP Camp4 Therapeutics CorpSold$1.6M
Aug 24, 2026CAMP Camp4 Therapeutics CorpSold$45
Aug 21, 2026CAMP Camp4 Therapeutics CorpSold$144K
Aug 20, 2026SKYE Skye Bioscience, IncSold$2.1K
Aug 20, 2026SKYE Skye Bioscience, IncSold$371
Aug 20, 2026SKYE Skye Bioscience, IncSold$15
Aug 20, 2026CAMP Camp4 Therapeutics CorpSold$521K
Aug 19, 2026SKYE Skye Bioscience, IncSold$20.1K
Aug 19, 2026SKYE Skye Bioscience, IncSold$3.6K
Aug 19, 2026SKYE Skye Bioscience, IncSold$143
Aug 19, 2026CAMP Camp4 Therapeutics CorpSold$215K
Aug 18, 2026SKYE Skye Bioscience, IncSold$17.1K
Aug 18, 2026SKYE Skye Bioscience, IncSold$695
Aug 18, 2026SKYE Skye Bioscience, IncSold$96.2K
Aug 3, 2026CAMP Camp4 Therapeutics CorpBought (not open market)$4.9M
Jun 10, 2026CAMP Camp4 Therapeutics CorpBought (not open market)—
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)—
Feb 6, 2026SKYE Skye Bioscience, IncBought (not open market)—

Companies traded

  • SKYE Skye Bioscience, Inc: 25 sales, last Sep 23, 2026
  • CAMP Camp4 Therapeutics Corp: 1 buy, 5 sales, last Aug 27, 2026
  • ELVN Enliven Therapeutics, Inc: other filings, last Feb 23, 2023
  • PEAR Pear Therapeutics, Inc: other filings, last Dec 3, 2021
  • FVAM 5:01 Acquisition Corp: other filings, last Nov 30, 2020
  • SCPH scPharmaceuticals Inc: 1 buy, last May 26, 2020
  • FLXN Flexion Therapeutics Inc: other filings, last Mar 3, 2014

Get free alerts when Andrew J. Schwab files a new trade →